The Royal Brompton Hospital
Welcome,         Profile    Billing    Logout  
 19 Trials 
27 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Abouzgheib, Wissam
SPRAY-CB, NCT03893370: RejuvenAir® System Trial for COPD With Chronic Bronchitis

Active, not recruiting
N/A
210
Europe, US
RejuvenAir System, Sham Control Procedure
CSA Medical, Inc.
Chronic Bronchitis
05/25
09/26
Hill, Jonathan
EUROSHOCK, NCT03813134: Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock

Recruiting
N/A
428
Europe
Percutaneous coronary intervention (PCI), Pharmacological Support, VA-ECMO, Veno-Arterial Extra Corporeal Membrane Oxygenation.
University of Leicester, European Commission, University of Glasgow, KU Leuven, University of East Anglia, Deutsches Herzzentrum Muenchen, A.O. Ospedale Papa Giovanni XXIII, Chalice Medical Ltd, Ludwig-Maximilians - University of Munich, University of Tromso, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Paula Stradina Liniska Universitates, Accelopment AG, Universiteit Antwerpen, Cardiovascular European Research Centre (CERC)
Cardiogenic Shock
03/23
02/24
NCT06181240: Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE)

Recruiting
N/A
400
Europe
Intravascular lithotripsy
Bolt Medical
Coronary Artery Disease, Coronary Artery Calcification
04/25
03/26
ORBITA-COSMIC, NCT04892537: Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia and Microvascular Resistance

Recruiting
N/A
50
Europe
Coronary Sinus Reducer, CSR, Placebo Procedure
Imperial College London, Medical Research Council, Imperial College Healthcare Nissen Fund
Refractory Angina
01/24
01/24
NCT05842915: The National Musculoskeletal Audit and Research Database

Recruiting
N/A
22000
Europe
Questionnaire
Keele University
Musculoskeletal Diseases
06/28
06/28
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27
Shah, Pallav
NCT03892694: Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis

Active, not recruiting
N/A
32
Europe
RejuvenAir System, Sham
CSA Medical, Inc.
COPD, Chronic Bronchitis
07/22
06/24
COPD-ENVIRON, NCT03010592: Studying the Airway Microenvironment in Patients Undergoing Surgical and Bronchoscopic Interventions for COPD

Recruiting
N/A
80
Europe
Royal Brompton & Harefield NHS Foundation Trust
Chronic Obstructive Pulmonary Disease, Emphysema, Chronic Bronchitis
01/23
01/23
NCT04459351: PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs

Recruiting
N/A
500
Europe
Chelsea and Westminster NHS Foundation Trust
Coronavirus, Corona Virus Infection, COVID-19, 2019nCoV, 2019 Novel Coronavirus Infection
05/23
06/23
CONVERT, NCT04559464: Fissure Closure With the AeriSeal System for ing Collateral Ventilation Status

Completed
N/A
102
Europe, RoW
AeriSeal, Zephyr Valves, Bronchoscopic Lung Volume Reduction (BLVR), Zephyr System
Pulmonx Corporation
Emphysema, COPD, Severe Emphysema
10/23
10/24
NCT06035120: An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema

Recruiting
N/A
200
Europe, US, RoW
AeriSeal System
Pulmonx Corporation
Emphysema, Pulmonary, Emphysema or COPD
06/27
03/28
AB1MALT, NCT05786625: Bronchoscopic Microwave Ablation of Lung Tissue

Recruiting
N/A
32
Europe
Ablation
Creo Medical Limited, Avania
Lung Cancer
03/25
03/26
SPRAY-CB, NCT03893370: RejuvenAir® System Trial for COPD With Chronic Bronchitis

Active, not recruiting
N/A
210
Europe, US
RejuvenAir System, Sham Control Procedure
CSA Medical, Inc.
Chronic Bronchitis
05/25
09/26
NCT05867953: Assessment of Tool Placement in Pulmonary Nodule(s) Using a Robotic Navigational Bronchoscopy System

Active, not recruiting
N/A
200
Europe
Biopsy with the Robotic- Ion Endoluminal System with Adjunct Real-time Imaging
Intuitive Surgical
Lung Cancer
04/24
05/25
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis

Active, not recruiting
N/A
270
Europe, US
RheOx Bronchial Rheoplasty, Sham Procedure
Gala Therapeutics, Inc.
Chronic Bronchitis
05/24
10/25
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD

Active, not recruiting
N/A
464
Europe, US
Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care
Nuvaira, Inc.
COPD
10/24
09/28
NCT06423690: First in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System

Recruiting
N/A
15
Europe, RoW
EAS1 System
Snipe Medical
Lung Cancer
05/25
07/25
BREATHE-2, NCT05949645: Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema

Active, not recruiting
N/A
30
Europe
Apreo Implant Group
Apreo Health, Inc.
Emphysema or COPD
10/24
06/26
909REM, NCT04847622: Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.

Completed
N/A
451
Europe, RoW
Remdesivir
NEAT ID Foundation, Gilead Sciences
Covid19
04/21
04/21
Simmonds, Nicholas J
CHOICES, NCT06468527: Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF

Recruiting
2
52
Europe
Diponecaftor, Placebo
Kors van der Ent, European Union
Cystic Fibrosis
04/25
06/25
CAR-CF, NCT04863573: COVID-19 Antibody Responses In Cystic Fibrosis

Recruiting
N/A
1000
Europe
Queen's University, Belfast, Cystic Fibrosis Foundation
Covid19, Cystic Fibrosis
05/24
05/24
YOGA-CF, NCT06120465: (Yoga Outcomes Get Assessed in Cystic Fibrosis)

Recruiting
N/A
314
Europe
Yoga
Royal Brompton & Harefield NHS Foundation Trust
Cystic Fibrosis
10/25
10/25
Stanford, Gemma
RExA-CF, NCT06565832: Reproducibility of Virtual Exercise Assessments Versus Face-to-face Exercise Testing in Adults With Cystic Fibrosis

Completed
N/A
19
Europe
One-Minute Sit-to-Stand Test, Chester Step Test
Royal Brompton & Harefield NHS Foundation Trust, King's College London
Cystic Fibrosis
08/23
08/23
YOGA-CF, NCT06120465: (Yoga Outcomes Get Assessed in Cystic Fibrosis)

Recruiting
N/A
314
Europe
Yoga
Royal Brompton & Harefield NHS Foundation Trust
Cystic Fibrosis
10/25
10/25
Orton, Christopher
PASSPORT, NCT04716023: Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19

Recruiting
N/A
42
Europe
Imperial College London
Copd, COVID-19, Asthma, Small Airways Disease
08/21
02/22
Tana, Anand
SPRAY-CB, NCT03893370: RejuvenAir® System Trial for COPD With Chronic Bronchitis

Active, not recruiting
N/A
210
Europe, US
RejuvenAir System, Sham Control Procedure
CSA Medical, Inc.
Chronic Bronchitis
05/25
09/26
NCT06423690: First in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System

Recruiting
N/A
15
Europe, RoW
EAS1 System
Snipe Medical
Lung Cancer
05/25
07/25

Download Options